| 000 | 01733 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515080004.0 | ||
| 264 | 0 | _c20081229 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1473-1150 | ||
| 024 | 7 |
_a10.1038/sj.tpj.6500469 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParé, L | |
| 245 | 0 | 0 |
_aTranscription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin? _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _cOct 2008 |
||
| 300 |
_a315-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 |
_aThymidylate Synthase _xgenetics |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMarcuello, E | |
| 700 | 1 | _aAltés, A | |
| 700 | 1 | _adel Rio, E | |
| 700 | 1 | _aSedano, L | |
| 700 | 1 | _aBarnadas, A | |
| 700 | 1 | _aBaiget, M | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 8 _gno. 5 _gp. 315-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.tpj.6500469 _zAvailable from publisher's website |
| 999 |
_c17216538 _d17216538 |
||